A 2022 article from The Atlantic explores "Paxlovid mouth," a common side effect of the COVID-19 antiviral characterized by a persistent, metallic taste known as dysgeusia. While reported in only 5.6% of clinical trials, experts suggest the issue, caused by nirmatrelvir activating taste receptors, is far more prevalent in real-world use. For more details, visit The Atlantic . Paxlovid Mouth Is Real—And Gross - The Atlantic
“I imagine this is what grapefruit juice mixed with soap would taste like.” By Rachel Gutman-Wei. Lambert / Getty; The Atlantic. The Atlantic Rebound COVID Is Just the Start of Paxlovid's Mysteries A 2022 article from The Atlantic explores "Paxlovid